Google, Microsoft May Pose Threats to Patient Privacy


By Maureen McKinney

April 22, 2008 | The entry of corporate behemoths like Google and Microsoft into the health information industry could have fundamental impacts on patient privacy, as well as on clinical research, according to an April 17 article in the New England Journal of Medicine.

The article, entitled, “Tectonic Shifts in the Health Information Economy,” differentiated personally controlled health records (PCHRs) from basic personal health records because PCHRs place primary control of data use and disclosure in the hands of patients. The authors cited the need for collaboration among PCHR providers, academic medical centers and the government in order to reach a consensus about appropriate methods of preserving data security and conducting research.

“Giving someone access to data that is institutionally controlled may have some benefits for the patient including insight into their own care, but with PCHRs, we go well beyond the walls of the institution,” explained Kenneth Mandl, associate professor at Children’s Hospital Boston, and co-author of the article. “Patients can engage with other institutions and entities, while the data flows into a repository that is exclusively controlled by the patient.”

One major concern with this dramatic increase in data liquidity, said Mandl, is that corporate entities entering the personal health record field are not held to the same standards as an academic research institution. Because companies like Google currently say they do not have to comply with the requirements and safeguards of the Health Insurance Portability and Accountability Act (HIPAA), there is no indication if they will adhere to research standards, he said.

“Under HIPAA, if one is to do research, they go before an institutional review board, which operates under the federal government and reviews protocols on how the data should be used,” Mandl said. “There are restrictions as far as aggregating patient data, benefits, risks, and notification. That’s a clear system of oversight, but with PCHRs, data from the repositories may be used for various kinds of research including drug approval and marketing.”

In addition, Mandl said, academic research centers may be at a disadvantage because not only do they have to comply with HIPAA protocols, they also might not have access to patient data pools as large as those of HealthVault and Google. If the largest and most complete databases reside on PCHR servers, it prompts questions about those companies’ research missions, the authors said.

In one example scenario provided in the article, a patient grants PCHR access to a clinical trial of a new medication, a medical social networking site, and an government-sponsored postmarketing surveillance program—none of which provide any informational control to medical centers.

“There is a reasonable argument that such control has been parochial and has created inefficiencies in fostering scientific discoveries and in delivering high-quality clinical care,” the authors said. “Nonetheless, if the pendulum swings the other way, and entire generation of clinical researchers in training will find themselves with second-class or no access to the best research resources.”

Patient privacy in PCHRs also remains uncertain and depends largely on how the hosting services of these companies approach the issue and inform their clients about the risks of certain types of disclosures, said Isaac Kohane, associate professor at Children’s Hospital Boston, director of the hospital’s informatics program, and co-author of the article.

Mandl and Kohane cited several critical steps that must be taken in order for PCHRs to be effective including the free exchange of patient data using agreed-upon standards, greater adoption of electronic health records, and new methods for protecting identity and security.

“Frankly, we don’t know what the optimal way is right now,” said Mandl. “We do think patients deserve guideposts, so we need to find the right mix that encourages discovery and, at the same time, protects the individual. That’s a conversation that PCHR service providers and medical centers need to be having.”

Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

Managed Innovation, Assured Compliance

sponsored by SAS

Discovery organizations are identifying a lot of promising compounds, but clinical research processes haven't kept pace with timely testing of all those potential therapies. This white paper describes how SAS® Drug Development supports true innovation across the clinical trial process.

In this white paper you will learn how to:

  • Assemble data to foster better collaboration
  • Get up-to-date information during clinical trials
  • Make informed decisions earlier in the trial process
    Download now


Addressing Life Sciences Constantly Growing Data Challenges Research Environments
Sponsored by BlueArc
The continued explosion of raw experimental data, the increased use of video, the growing adoption of new data retention practices, and the move to high throughput computational workflows are all placing new demands on the way life sciences organizations store and manage their data.

Download this white paper to learn about:

  • Factors driving the data explosion in the life sciences
  • New data management issues that must be addressed
  • HPC trends that are placing new demands on storage
  • Storage solution attributes that address performance, manageability, and energy efficiency. Download now


“Storage for Science – Methods for Managing Large and Rapidly Growing Data Stores in Life Science Research Environments” sponsored by Isilon
Large and rapidly growing stores of file-based and other data are a hallmark of life science research and bioinformatics. Determining how best to manage those data stores has become a significant challenge for Researchers and IT Pros alike.

This paper is intended to:

  • Provide guidance on the many storage requirements common to Life Science research;
  • Explain the evolution of modern storage architectures;
  • Summarize the major data storage architectures currently in use.

Additionally, it will present the Isilon IQ clustered storage product as a strong and flexible solution to those needs. Download now



Life Science Webcasts & Podcasts

Adobe

Hospital Paperwork No Longer Has to Be an In-patient Procedure

How many times have you filled out that same patient registration form when visiting a doctor or the hospital? If you are a hospital administrator, nurse or registrar, you know that your patients and particularly your staff have managed hundreds of consent forms for medication, procedures, anesthesia, and HIPAA. Paperwork redundancy has become a significant bottleneck in the healthcare system. In this podcast, we’ll learn about how Adobe solutions for healthcare can help you streamline your paperwork and stop making paperwork an in-patient procedure.

Download Now



More Podcasts

Job Openings

Merck ~Sr. Computational Biologist
Apply and develop computational biology/informatics techniques to support Oncology drug discovery; collaborate with scientists to develop in-depth understanding of deregulated signaling pathways, discover novel targets and treatment strategies, and identify associated candidate biomarkers. Ph.D. in Computational Biology/Bioinformatics, solid statistics background and hands-on modeling and informatics techniques related to drug discovery experience required. Click to Apply

Oxford Nanopore Technologies, Oxford, UK
We seek a highly motivated individual to lead the administration, expansion and maintenance of our IT infrastructure, supporting our business operations and technological development of a DNA third generation sequencing system. Includes administration and configuration of core corporate servers, high performance scientific computing and disk systems, security systems, network infrastructure and backups, maintenance of service levels, implementation of any IT related legal compliance issues and policies, and disaster recovery. to apply: www.nanoporetech.com/vacancies

Related Resources & Products

Disease-Related Biomarkers: Their Potential in Patient Screening, Prognosis, and Stratification
Disease-Related Biomarkers: Their Potential in Patient Screening, Prognosis, and Stratification
Patient Recruitment and Retention 2008
Patient Recruitment and Retention 2008



For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to [email protected].